Where is INDICUS PHARMA located?

INDICUS PHARMA is headquartered in Raleigh, United States.

Where does INDICUS PHARMA rank among its competitors?

INDICUS PHARMA ranks 61st amongst 63 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Pfizer, which secured $117M in Jun, 2023.

Who are the top competitors of INDICUS PHARMA?

INDICUS PHARMA's top competitors include Pfizer, Cost Plus Drug and Lovell Government Services. Among them, Pfizer secured the most recent funding round in June, 2023.

INDICUS PHARMA - 2026 Company Profile & Competitors

Company Details

Developer and marketer of niche generic pharmaceutical formulations for sale. Business operations focus on the creation of complex molecules through collaborative research and development efforts. Products consist of specialized generic formulations developed to address markets with limited therapeutic competition. Finished pharmaceutical products are distributed through commercial partnerships.

Key Metrics

Location

Raleigh, United States

Stage

Unfunded

Ranked

61^st among 63 active competitors

Similar Companies

Pfizer & 476 more

View INDICUS PHARMA's full profile

INDICUS PHARMA has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of INDICUS PHARMA include Pfizer, Cost Plus Drug and Lovell Government Services. Here is the list of Top 10 competitors of INDICUS PHARMA, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Pfizer 1849, New York City (United States), Public	Provider of pharmaceutical products for multiple disease treatments	-	Berkshire Hathaway, Alcor Fund & 16 others	67/100
2nd	Cost Plus Drug 2016, Dallas (United States), Unfunded	Distributor of generic drugs	-	-	46/100
3rd	Lovell Government Services 2013, Pensacola (United States), Unfunded	Distributor of pharmaceutical products	-	-	43/100
4th	Aurobindo Pharma USA 1994, East Windsor (United States), Unfunded	Distributor of generic drugs	-	-	38/100
5th	YARAL Pharma 2021, Parsippany (United States), Unfunded	Provider of authorized generic and complex generic medicines to enhance healthcare	-	-	34/100
6th	Auburn 1993, Rochester Hills (United States), Unfunded	Wholesaler distributes generic drugs purchased directly from manufacturers to pharmacies	-	-	28/100
7th	KeySource 1996, Cincinnati (United States), Acquired	Distributor of pharmaceutical products	-	HEPCO Capital Management	26/100
8th	Bayshore Pharmaceuticals 2011, Short Hills (United States), Acquired	Manufacturer of pharmaceutical products	-	-	26/100
9th	Red Oak Sourcing 2014, Foxborough (United States), Seed	Distributor of generic drugs	$2.1M	-	26/100
10th	Marley Drug 2003, Winston-salem (United States), Acquired	Supplier of pharmaceutical products	-	-	25/100
61st	INDICUS PHARMA Raleigh (United States), Unfunded	Developer and marketer of niche generic pharmaceutical formulations for sale	-	-	16/100